Skip to content

Effects of Exercise Training on Mechanoreflex and Metaboreflex Control in Heart Failure Patients

Effects of Exercise Training on Mechanoreflex and Metaboreflex Control of Muscle Sympathetic Nerve Activity in Heart Failure Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01884142
Enrollment
34
Registered
2013-06-21
Start date
2008-03-31
Completion date
2014-01-31
Last updated
2021-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure

Brief summary

The investigators hypothesize that exercise training would improve the mechanoreflex and metaboreflex control in heart failure patients.

Interventions

OTHERAerobic Exercise Training

Sponsors

Fundação de Amparo à Pesquisa do Estado de São Paulo
CollaboratorOTHER_GOV
Conselho Nacional de Desenvolvimento Científico e Tecnológico
CollaboratorOTHER_GOV
University of Sao Paulo General Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
30 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Patients with systolic heart failure; * New York Heart Association (NYHA) class II-III; * Left ventricular ejection fraction less than 40%; * Peak Oxygen Consumption less than 20 ml/Kg/min; * Stable Clinical Status.

Exclusion criteria

* Chronic Obstructive Pulmonary Disease; * Neuromuscular Diseases; * Orthopedic Diseases; * Neurologic Diseases; * Neoplastic Diseases; * Recent myocardial infarction or cardiac surgery (less than 6 months); * Unstable angina pectoris; * Atrial Fibrillation; * Pacemakers users; * Changing medication or hospital admission.

Design outcomes

Primary

MeasureTime frameDescription
Autonomic Control4 monthsMechanoreceptors were activated by passive exercise and metaboreceptors by post-exercise circulatory arrest
Muscular Evaluation4 monthsMuscular evaluation will be done by muscle gene expression

Secondary

MeasureTime frameDescription
Functional Capacity4 monthsFunctional Capacity will be determined by cardiopulmonary exercise testing
Muscle Blood Flow4 monthsForearm blood flow will be assessed by venous occlusion plethysmography
Blood Pressure4 monthsBlood pressure will be monitored non-invasively

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026